Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Interpace Biosciences, Inc. (IDXG) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Interpace Biosciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1054102.
Total stock buying since 2005: $1,556,924.
Total stock sales since 2005: $119,681.
Total stock option exercises since 2005: $178,883.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 0 | $0 | 29,824 | $0 |
| 2023 | 0 | $0 | 0 | $0 | 8,651 | $0 |
| 2021 | 94,105 | $354,325 | 0 | $0 | 0 | $0 |
| 2020 | 0 | $0 | 0 | $0 | 5,000 | $0 |
| 2018 | 0 | $0 | 0 | $0 | 2,000 | $0 |
| 2015 | 0 | $0 | 6,775 | $5,281 | 0 | $0 |
| 2014 | 390,300 | $651,430 | 0 | $0 | 0 | $0 |
| 2013 | 20,400 | $106,286 | 0 | $0 | 0 | $0 |
| 2011 | 0 | $0 | 0 | $0 | 11,472 | $94,529 |
| 2010 | 1,000 | $10,601 | 0 | $0 | 2,991 | $31,854 |
| 2009 | 18,460 | $86,174 | 0 | $0 | 0 | $0 |
| 2008 | 77,554 | $342,876 | 0 | $0 | 0 | $0 |
| 2006 | 0 | $0 | 10,000 | $114,400 | 10,000 | $52,500 |
| 2005 | 450 | $5,232 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-12 | 0 | $0 | 0 | $0 | 1,111 | $0 |
| 2024-07 | 0 | $0 | 0 | $0 | 15,112 | $0 |
| 2024-02 | 0 | $0 | 0 | $0 | 6,045 | $0 |
| 2024-01 | 0 | $0 | 0 | $0 | 7,556 | $0 |
| 2023-12 | 0 | $0 | 0 | $0 | 1,095 | $0 |
| 2023-07 | 0 | $0 | 0 | $0 | 7,556 | $0 |
| 2021-05 | 10,855 | $94,221 | 0 | $0 | 0 | $0 |
| 2021-03 | 42,200 | $129,976 | 0 | $0 | 0 | $0 |
| 2021-02 | 41,050 | $130,128 | 0 | $0 | 0 | $0 |
| 2020-07 | 0 | $0 | 0 | $0 | 5,000 | $0 |
| 2018-02 | 0 | $0 | 0 | $0 | 2,000 | $0 |
| 2015-12 | 0 | $0 | 1,748 | $1,345 | 0 | $0 |
| 2015-11 | 0 | $0 | 5,027 | $3,936 | 0 | $0 |
| 2014-11 | 390,300 | $651,430 | 0 | $0 | 0 | $0 |
| 2013-11 | 20,400 | $106,286 | 0 | $0 | 0 | $0 |
| 2011-03 | 0 | $0 | 0 | $0 | 11,472 | $94,529 |
| 2010-11 | 1,000 | $10,601 | 0 | $0 | 2,991 | $31,854 |
| 2009-08 | 13,460 | $69,374 | 0 | $0 | 0 | $0 |
| 2009-05 | 5,000 | $16,800 | 0 | $0 | 0 | $0 |
| 2008-12 | 50,000 | $200,000 | 0 | $0 | 0 | $0 |
| 2008-11 | 19,000 | $72,908 | 0 | $0 | 0 | $0 |
| 2008-06 | 8,554 | $69,968 | 0 | $0 | 0 | $0 |
| 2006-03 | 0 | $0 | 10,000 | $114,400 | 10,000 | $52,500 |
| 2005-06 | 450 | $5,232 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-01 | Mccarthy Christopher (Chief Financial Officer) | Option Ex | 1,111 | .00 | 0 |
| 2024-07-27 | Mccarthy Christopher (Chief Financial Officer) | Option Ex | 15,112 | .00 | 0 |
| 2024-02-01 | Mccarthy Christopher (Chief Financial Officer) | Option Ex | 6,045 | .00 | 0 |
| 2024-01-31 | Mccarthy Christopher (Chief Financial Officer) | Option Ex | 7,556 | .00 | 0 |
| 2023-12-01 | Mccarthy Christopher (Chief Financial Officer) | Option Ex | 1,095 | .00 | 0 |
| 2023-07-31 | Mccarthy Christopher (Chief Financial Officer) | Option Ex | 7,556 | .00 | 0 |
| 2021-05-21 | Burnell Thomas W. (President & CEO) | Buy | 10,855 | 8.68 | 94,221 |
| 2021-03-01 | Kamin Peter | Buy | 42,200 | 3.08 | 129,976 |
| 2021-02-26 | Kamin Peter | Buy | 41,050 | 3.17 | 130,128 |
| 2020-07-29 | Early James | Option Ex | 5,000 | .00 | 0 |
| 2018-02-26 | Richard Gregory (Chief Commerical Officer) | Option Ex | 2,000 | .00 | 0 |
| 2015-12-01 | Melillo Gerald R Jr (President, Sales Services) | Sale | 1,748 | .77 | 1,345 |
| 2015-11-30 | Melillo Gerald R Jr (President, Sales Services) | Sale | 765 | .80 | 612 |
| 2015-11-25 | Melillo Gerald R Jr (President, Sales Services) | Sale | 4,262 | .78 | 3,324 |
| 2014-11-25 | Miao Graham G (CFO) | Buy | 21,400 | 1.65 | 35,310 |
| 2014-11-24 | Miao Graham G (CFO) | Buy | 600 | 1.65 | 990 |
| 2014-11-10 | Lurker Nancy (CEO) | Buy | 16,000 | 1.69 | 27,088 |
| 2014-11-07 | Melillo Gerald R Jr (President, Sales Services) | Buy | 5,000 | 1.58 | 7,900 |
| 2014-11-07 | Lurker Nancy (CEO) | Buy | 33,000 | 1.77 | 58,509 |
| 2014-11-07 | Smith Jeffrey Edward (VP of Corporate Development) | Buy | 200,000 | 1.62 | 325,000 |
| 2014-11-06 | Lurker Nancy (CEO) | Buy | 1,000 | 1.60 | 1,600 |
| 2014-11-05 | Lurker Nancy (CEO) | Buy | 56,000 | 1.73 | 96,936 |
| 2014-11-05 | Belle Gerald P. | Buy | 57,300 | 1.71 | 98,097 |
| 2013-11-18 | Belle Gerald P. | Buy | 13,000 | 5.25 | 68,250 |
| 2013-11-15 | Belle Gerald P. | Buy | 7,400 | 5.14 | 38,036 |
| 2011-03-15 | Lurker Nancy (CEO) | Option Ex | 11,472 | 8.24 | 94,529 |
| 2010-11-18 | Belle Gerald P. | Buy | 1,000 | 10.60 | 10,601 |
| 2010-11-16 | Drazner Howard (President, Pharmakon) | Option Ex | 2,991 | 10.65 | 31,854 |
| 2009-08-21 | Smith Jeffrey Edward (CFO) | Buy | 2,500 | 5.25 | 13,125 |
| 2009-08-18 | Lurker Nancy (CEO) | Buy | 6,000 | 5.17 | 31,038 |
| 2009-08-17 | Lurker Nancy (CEO) | Buy | 3,960 | 5.05 | 19,998 |
| 2009-08-11 | Belle Gerald P. | Buy | 1,000 | 5.21 | 5,213 |
| 2009-05-14 | Vecsi Jan Martens | Buy | 5,000 | 3.36 | 16,800 |
| 2008-12-02 | Smith Jeffrey Edward (CFO) | Buy | 50,000 | 4.00 | 200,000 |
| 2008-11-26 | Ryan Frank J | Buy | 6,000 | 4.00 | 24,000 |
| 2008-11-24 | Federspiel John | Buy | 3,000 | 3.82 | 11,448 |
| 2008-11-24 | Vecsi Jan Martens | Buy | 10,000 | 3.75 | 37,460 |
| 2008-06-26 | Smith Jeffrey Edward (CEO) | Buy | 6,054 | 8.26 | 50,006 |
| 2008-06-11 | Marquard Michael (CEO) | Buy | 2,500 | 7.99 | 19,962 |
| 2006-03-10 | Jacobson Beth (Former Exec VP & GC) | Sale | 10,000 | 11.44 | 114,400 |
| 2006-03-10 | Jacobson Beth (Former Exec VP & GC) | Option Ex | 10,000 | 5.25 | 52,500 |
| 2005-06-14 | Sullivan Stephen J (Director) | Buy | 450 | 11.63 | 5,232 |
Insider trading activities including stock purchases, stock sales, and option exercises of IDXG listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Interpace Biosciences, Inc. (symbol IDXG, CIK number 1054102) see the Securities and Exchange Commission (SEC) website.